Biotechnology Startups in Paris

Gradient Denervation Technologies develops a medical device for a transvascular treatment of pulmonary hypertension.

Epigene Labs designs genomics-driven drug for precision oncology.

Arbiom is a biotech company that develops non-food biomass processing technology.

SparingVision is a biotechnology company developing genomic medicines for the treatment of blinding inherited retinal diseases.

WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.

Cyllene Therapeutics is a French biotechnology business that is pioneering a novel approach termed pinpoint gene therapy.

Thabor Therapeutics develops innovative treatments for mucosal inflammatory diseases.

A Paris-based biotechnology company .

Core Biogenesis is a biotechnology company building next-generation recombinant protein production technologies.

PK MED focuses on the unique creation of custom-designed, intravenous, and biodegradable micro-implants.

Omini develops a biosensor platform that allows the simultaneous detection of multiple biomarkers.

Carvolix is develops innovative new-generation mini-invasive implants to restore essential physiological functions.

Spotlight Medical develops AI tests to revolutionize cancer treatment, providing everyone with the best possible chance to beat cancer.

AgenT develops the first blood diagnosis to detect Alzheimer's disease from the asymptomatic stage.

En Carta Diagnostics develops molecular diagnostic technologies that enable the detection of DNA and RNA pathogens at the point of care.

InnovaFeed is a biotech company that produces insect-based protein for the feed industry.

Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases.

TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.

Oria Bioscience is a pure biotechnology company that produces intact organelles for therapeutic opportunities.

Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

EndoGene.Bio decodes epigenetics in menstrual blood to unlock patient tissue-level insights for therapeutic discovery and diagnostics.

Qubit Pharmaceuticals is an EIT Health Headstart laureate and is incubated at Paris Biotech Santé.

Abivax develops medicines that alter the body's natural immune system mechanisms.

Eligobiotics provides a new approach to explore, understand, and control bacterial ecosystems both in human and animals.